Q2 2023 Holdings
Filed 2023-08-14 | 17 holdings | $82.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $10.8M | 105,558 | 13.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $10.3M | 487,631 | 12.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.3M | 266,961 | 12.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.3M | 223,382 | 8.8% |
| Geron Corp(GERN) | COM | 374163103 | $6.8M | 2,123,162 | 8.3% |
| Merus NV | COM | N5749R100 | $5.2M | 199,221 | 6.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.8M | 201,752 | 5.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $4.7M | 91,413 | 5.6% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $4.2M | 390,418 | 5.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $4.0M | 800,000 | 4.9% |
| Praxis Precision Medicines I | COM | 74006W108 | $3.7M | 3,200,000 | 4.5% |
| Jasper Therapeutics Inc | COM | 471871103 | $3.4M | 2,517,232 | 4.2% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $2.9M | 914,630 | 3.5% |
| Medavail Holdings Inc | COM | 58406B103 | $1.4M | 5,894,897 | 1.8% |
| Mdxhealth SA | SPONSORED ADS | 58286E102 | $1.2M | 349,552 | 1.4% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.0M | 653,396 | 1.3% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $403.3K | 403,284 | 0.5% |